Form D — Latigo Biotherapeutics, Inc.
0002056611-25-000001 · filed Feb 13, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $149,999,990
- Total sold
- $49,999,995
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Latigo Biotherapeutics, Inc.
- CIK
- 2056611
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1300 RANCHO CONEJO BLVD. SUITE 305
THOUSAND OAKS, CA 91320 - Phone
- 805-716-2927
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nima Farzan · Executive OfficerThousand Oaks, CA Find on LinkedIn ↗
-
Kevin Raidy · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Jim Tananbaum · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Beth Seidenberg · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Deborah Palestrant · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Tim Walbert · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Nancy Stagliano · DirectorThousand Oaks, CA Find on LinkedIn ↗
-
Tim Lugo · Executive OfficerThousand Oaks, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗